NCT07761871 Exercise and Nutritional Intervention in Patients With Melanoma Receiving Immunotherapy Status RECRUITING Phase NA
NCT07686835 Dietary Fiber to Induce Gut Microbiota-mediated Response to Immunotherapy in Melanoma. Status RECRUITING Phase PHASE2
NCT07660666 Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint Inhibitor Status NOT_YET_RECRUITING Phase NA
NCT07651020 The Clinical Application Value of SPECT Imaging Targeting LRRC15 in Malignant Tumors Status COMPLETED Phase N/A
NCT07649252 A Study of Patient Characteristics and Treatment Patterns in Real-world Melanoma Patients Treated With Dabrafenib and Trametinib or Encorafenib and Binimetinib in Japan Status COMPLETED Phase N/A
NCT07644897 Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced Melanoma Status RECRUITING Phase PHASE2
NCT07628634 Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT07574047 MELCHRONO: A Prospective Randomized Study Investigating Chrono-immunotherapy for Advanced Melanoma. Status NOT_YET_RECRUITING Phase PHASE2
NCT07552467 Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors Status RECRUITING Phase N/A
NCT07529080 Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial Status NOT_YET_RECRUITING Phase NA
NCT07524114 Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK) Status RECRUITING Phase N/A
NCT07518043 A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors Status RECRUITING Phase PHASE1
NCT07517653 Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07511036 PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma Status NOT_YET_RECRUITING Phase PHASE2
NCT07476326 Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma Status NOT_YET_RECRUITING Phase PHASE1
NCT07475572 A Randomized, Double-Blind, Pharmacokinetic Similarity Study to Compare AVT32-DRL_PB With Keytruda® in Participants With Fully Resected Melanoma Status NOT_YET_RECRUITING Phase PHASE1
NCT07444606 Dose Ranging, Toxicity Seeking, Phase 1 Trial of Oncolytic Adenoviral Therapy for Melanoma Intracranial and Extracranial Metastases Status NOT_YET_RECRUITING Phase PHASE1